Demographic disparities in access to COVID-19 clinical trial sites across the United States: a geospatial analysis
{{output}}
Throughout the COVID-19 pandemic, underserved populations, such as racial and ethnic minority communities, were disproportionately impacted by illness and death. Ensuring people from diverse backgrounds have the ability to participate in clinical trials is key... ...
